IHP THERAPEUTICS INC
Empowering individuals with sickle cell disease
San Carlos, United States · Founded 2023
- Headquarters
- San Carlos, California
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- ihptherapeutics.com
About
IHP Therapeutics is developing IHP-102, a novel dual P-selectin and complement inhibitor for the treatment of acute vaso-occlusive crisis in sickle cell disease. IHP-102 is designed as the first self-administered rescue therapeutic, enabling home-based care. The company has received NIH SBIR, HEAL, and DoD grants totaling over $12M.
Summary
IHP THERAPEUTICS INC is a Biotech company based in San Carlos, United States, founded in 2023.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ihp-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/ihp-therapeutics-inc" alt="IHP THERAPEUTICS INC on Indexed.vc" width="260" height="76" /></a>